Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Filana Therapeutics's ebitda for the twelve months ending Jun 30, 2021 was -$12.72M. For fiscal 2020 it was -$6.42M. The highest annual figure on record is -$3.35M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$6.42M | – |
| FY2019 | Dec 31, 2019 | -$4.90M | – |
| FY2018 | Dec 31, 2018 | -$6.59M | – |
| FY2017 | Dec 31, 2017 | -$11.88M | – |
| FY2016 | Dec 31, 2016 | -$14.90M | – |
| FY2015 | Dec 31, 2015 | -$14.16M | – |
| FY2014 | Dec 31, 2014 | -$12.42M | – |
| FY2012 | Dec 31, 2012 | -$3.78M | – |
| FY2011 | Dec 31, 2011 | -$3.35M | – |
| FY2010 | Dec 31, 2010 | -$13.47M | – |
| FY2009 | Dec 31, 2009 | -$6.50M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | -$5.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.44M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.16M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$765.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.14M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.43M | – |
| Q4 FY2018 | Dec 31, 2018 | -$733.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.27M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.44M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.15M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.41M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.58M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.15M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.75M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.53M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.53M | – |
See a number that looks wrong?